Balanced news tone
News Sentiment
ABEO sentiment intelligence
Abeona Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+9.1% over one week, +26.2% over four weeks, trend active, and materially above fair value.
Precision Trading with Abeona Therapeutics Inc. (ABEO) Risk Zones
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Abeona Therapeutics (ABEO) One Off US$152.4m Gain Tests Bullish Profitability Narrative
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- simplywall.st
ABEONA THERAPEUTICS ($ABEO) Releases Q4 2025 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Mar 2026 07:00
- Source
- Quiver Quantitative
Abeona Therapeutics (ABEO): Assessing Value After J-Code Milestone for ZEVASKYN Approval
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 12 Nov 2025 08:00
- Source
- simplywall.st
Loss-Making Abeona Therapeutics Inc. (NASDAQ:ABEO) Set To Breakeven
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jul 2025 07:00
- Source
- simplywall.st